EPISODE · Nov 8, 2022 · 22 MIN
India-UK FTA should be able to deal with public scrutiny
from BusinessLine Podcasts · host BusinessLine
The India-UK Free Trade Agreement is underway. According to reports, India is looking at greater market access for pharmaceutical products with the deal. However, the humanitarian group Doctors Without Borders mentioned that the India-UK FTA might hurt the supply of generic medicines globally. The group has also asked India and UK to keep Intellectual Property (IP) off the table. In this podcast, we discuss the views of pro-health groups about the India-UK Free Trade Agreement, the points of concern addressed by Doctors Without Border and others. --- Send in a voice message: https://podcasters.spotify.com/pod/show/business-line/message
Embed this episode
NOW PLAYING
India-UK FTA should be able to deal with public scrutiny
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.